ClinicalTrials.gov
public full text
Public Domain
Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions
The purpose of this study was to evaluate the relative bioavailability of the test formulation of furosemide 80 mg tablets (Ohm Laboratories, Inc.) with an already marketed reference formulation Lasix® (furosemide) 80 mg tablets (Aventis Pharmaceuticals NJ) under fasted conditions in healthy adult human subjects
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Leflunomide 20 mg Tablets Under Fasting Conditions#897384
- Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide#861983
- Bioequivalence Test of Hemay005 Tablets#838778
- Finasteride 5 mg Tablets, Non-fasting#1046318
- Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition#891366
Record · ID 854706
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive